Itoh Y - Search Results

1

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.

Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K. Sawai H, et al. Among authors: itoh y. Sci Rep. 2018 May 21;8(1):7958. doi: 10.1038/s41598-018-26217-7. Sci Rep. 2018. PMID: 29784950 Free PMC article.

2

Detection of minus-strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma.

Kobayashi S, Hayashi H, Itoh Y, Asano T, Isono K. Kobayashi S, et al. Among authors: itoh y. Cancer. 1994 Jan 1;73(1):48-52. doi: 10.1002/1097-0142(19940101)73:1<48::aid-cncr2820730110>3.0.co;2-l. Cancer. 1994. PMID: 8275436

3

Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.

Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N. Kasahara A, et al. Among authors: itoh y. J Viral Hepat. 2004 Mar;11(2):148-56. doi: 10.1046/j.1365-2893.2003.00481.x. J Viral Hepat. 2004. PMID: 14996350

4

Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis.

Yamauchi N, Itoh Y, Tanaka Y, Mizokami M, Minami M, Morita A, Toyama T, Yamaguchi K, Fujii H, Okanoue T. Yamauchi N, et al. Among authors: itoh y. J Gastroenterol. 2004 Jul;39(7):654-60. doi: 10.1007/s00535-003-1361-y. J Gastroenterol. 2004. PMID: 15293136

5

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.

Makiyama A, Itoh Y, Kasahara A, Imai Y, Kawata S, Yoshioka K, Tsubouchi H, Kiyosawa K, Kakumu S, Okita K, Hayashi N, Okanoue T. Makiyama A, et al. Among authors: itoh y. Cancer. 2004 Oct 1;101(7):1616-22. doi: 10.1002/cncr.20537. Cancer. 2004. PMID: 15378504 Free article.

6

Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis.

Minami M, Daimon Y, Mori K, Takashima H, Nakajima T, Itoh Y, Okanoue T. Minami M, et al. Among authors: itoh y. Oncogene. 2005 Jun 23;24(27):4340-8. doi: 10.1038/sj.onc.1208628. Oncogene. 2005. PMID: 15806150

7

Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapy.

Okanoue T, Minami M, Makiyama A, Sumida Y, Yasui K, Itoh Y. Okanoue T, et al. Among authors: itoh y. Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S89-91. doi: 10.1016/s1542-3565(05)00701-9. Clin Gastroenterol Hepatol. 2005. PMID: 16234069

8

Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts.

Okanoue T, Itoh Y, Minami M, Hashimoto H, Yasui K, Yotsuyanagi H, Takehara T, Kumada T, Tanaka E, Nishiguchi S, Izumi N, Sata M, Onji M, Yamada G, Okita K, Kumada H. Okanoue T, et al. Among authors: itoh y. Hepatol Res. 2008 Jan;38(1):27-36. doi: 10.1111/j.1872-034X.2007.00217.x. Hepatol Res. 2008. PMID: 18039201

9

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study.

Okanoue T, Itoh Y, Hashimoto H, Yasui K, Minami M, Takehara T, Tanaka E, Onji M, Toyota J, Chayama K, Yoshioka K, Izumi N, Akuta N, Kumada H. Okanoue T, et al. Among authors: itoh y. J Gastroenterol. 2009;44(9):952-63. doi: 10.1007/s00535-009-0087-x. Epub 2009 Jun 11. J Gastroenterol. 2009. PMID: 19517057

10

Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b.

Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Yuki NS, Itsui Y, Azuma S, Kakinuma S, Hige S, Itoh Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M; Ochanomizu-Liver Conference Study Group. Sakamoto N, et al. Among authors: itoh y. J Med Virol. 2011 May;83(5):871-8. doi: 10.1002/jmv.22038. Epub 2011 Feb 25. J Med Virol. 2011. PMID: 21360545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,275 results

Search Page